Inventory Summary of International Stem Cell Corporation

International Stem Cell Corporation's latest annual inventory in 2023 was 1.26 Million USD , down -8.74% from previous year.
International Stem Cell Corporation's latest quarterly inventory in 2024 Q1 was 1.27 Million USD , up 0.79% from previous quarter.
International Stem Cell Corporation reported annual inventory of 1.38 Million USD in 2022, up 16.89% from previous year.
International Stem Cell Corporation reported annual inventory of 1.18 Million USD in 2021, up 29.12% from previous year.
International Stem Cell Corporation reported quarterly inventory of 1.41 Million USD for 2024 Q2, up 11.15% from previous quarter.
International Stem Cell Corporation reported quarterly inventory of 1.26 Million USD for 2023 Q4, down -4.1% from previous quarter.

Annual Inventory Chart of International Stem Cell Corporation (2023 - 2005)

Historical Annual Inventory of International Stem Cell Corporation (2023 - 2005)

Year	Inventory	Inventory Growth
2023	1.26 Million USD	-8.74%
2022	1.38 Million USD	16.89%
2021	1.18 Million USD	29.12%
2020	917 Thousand USD	-26.4%
2019	1.24 Million USD	-16.99%
2018	1.5 Million USD	14.84%
2017	1.3 Million USD	-5.97%
2016	1.39 Million USD	-24.33%
2015	1.83 Million USD	21.09%
2014	1.51 Million USD	10.81%
2013	1.36 Million USD	14.18%
2012	1.19 Million USD	-5.44%
2011	1.26 Million USD	48.12%
2010	856.08 Thousand USD	35.6%
2009	631.3 Thousand USD	51.27%
2008	417.34 Thousand USD	137.62%
2007	175.63 Thousand USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	1.27 Million USD	0.79%
2024 Q2	1.41 Million USD	11.15%
2023 Q4	1.26 Million USD	-4.1%
2023 Q2	1.29 Million USD	0.15%
2023 Q1	1.29 Million USD	-6.5%
2023 Q3	1.31 Million USD	1.62%
2023 FY	1.26 Million USD	-8.74%
2022 FY	1.38 Million USD	16.89%
2022 Q2	1.36 Million USD	2.95%
2022 Q3	1.41 Million USD	3.97%
2022 Q1	1.32 Million USD	11.66%
2022 Q4	1.38 Million USD	-2.19%
2021 Q2	1.07 Million USD	1.71%
2021 Q3	1.13 Million USD	6.15%
2021 FY	1.18 Million USD	29.12%
2021 Q4	1.18 Million USD	3.95%
2021 Q1	1.05 Million USD	15.05%
2020 Q4	917 Thousand USD	-2.13%
2020 Q1	1.1 Million USD	-11.72%
2020 Q2	1.01 Million USD	-8.18%
2020 Q3	937 Thousand USD	-7.23%
2020 FY	917 Thousand USD	-26.4%
2019 Q4	1.24 Million USD	-11.57%
2019 Q3	1.4 Million USD	6.99%
2019 Q2	1.31 Million USD	-9.79%
2019 FY	1.24 Million USD	-16.99%
2019 Q1	1.46 Million USD	-2.73%
2018 Q4	1.5 Million USD	1.83%
2018 FY	1.5 Million USD	14.84%
2018 Q2	1.68 Million USD	21.44%
2018 Q1	1.38 Million USD	5.97%
2018 Q3	1.47 Million USD	-12.37%
2017 Q4	1.3 Million USD	-3.33%
2017 Q3	1.35 Million USD	-2.73%
2017 Q2	1.39 Million USD	-2.32%
2017 FY	1.3 Million USD	-5.97%
2017 Q1	1.42 Million USD	2.37%
2016 Q3	1.28 Million USD	-6.14%
2016 Q4	1.39 Million USD	8.26%
2016 FY	1.39 Million USD	-24.33%
2016 Q2	1.36 Million USD	-4.6%
2016 Q1	1.43 Million USD	-21.94%
2015 FY	1.83 Million USD	21.09%
2015 Q4	1.83 Million USD	-1.97%
2015 Q3	1.87 Million USD	6.54%
2015 Q2	1.75 Million USD	5.46%
2015 Q1	1.66 Million USD	9.95%
2014 FY	1.51 Million USD	10.81%
2014 Q2	1.47 Million USD	8.33%
2014 Q3	1.53 Million USD	4.29%
2014 Q4	1.51 Million USD	-1.04%
2014 Q1	1.35 Million USD	-0.88%
2013 Q1	1.2 Million USD	0.58%
2013 Q2	1.37 Million USD	13.6%
2013 Q3	1.36 Million USD	-0.73%
2013 Q4	1.36 Million USD	0.66%
2013 FY	1.36 Million USD	14.18%
2012 Q3	1.12 Million USD	-11.79%
2012 Q4	1.19 Million USD	6.86%
2012 FY	1.19 Million USD	-5.44%
2012 Q1	1.22 Million USD	-3.15%
2012 Q2	1.27 Million USD	3.58%
2011 Q2	1.32 Million USD	19.53%
2011 Q1	1.11 Million USD	29.92%
2011 Q3	1.49 Million USD	12.58%
2011 Q4	1.26 Million USD	-15.28%
2011 FY	1.26 Million USD	48.12%
2010 Q3	765.13 Thousand USD	8.92%
2010 Q4	856.08 Thousand USD	11.89%
2010 FY	856.08 Thousand USD	35.6%
2010 Q1	661.14 Thousand USD	4.73%
2010 Q2	702.47 Thousand USD	6.25%
2009 Q3	455.74 Thousand USD	28.43%
2009 Q2	354.87 Thousand USD	14.36%
2009 Q1	310.32 Thousand USD	-25.64%
2009 FY	631.3 Thousand USD	51.27%
2009 Q4	631.3 Thousand USD	38.52%
2008 Q4	417.34 Thousand USD	48.74%
2008 Q2	232.3 Thousand USD	19.23%
2008 Q1	194.84 Thousand USD	10.93%
2008 FY	417.34 Thousand USD	137.62%
2008 Q3	280.58 Thousand USD	20.78%
2007 Q2	54.11 Thousand USD	0.0%
2007 Q3	91.84 Thousand USD	69.72%
2007 Q4	175.63 Thousand USD	91.24%
2007 FY	175.63 Thousand USD	0.0%
2007 Q1	- USD	-100.0%
2006 FY	- USD	0.0%
2006 Q3	- USD	0.0%
2006 Q2	- USD	0.0%
2006 Q1	- USD	0.0%
2006 Q4	20.14 Thousand USD	0.0%
2005 FY	- USD	0.0%

Peer Inventory Comparison of International Stem Cell Corporation

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	18.83%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-12158.565%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	25.575%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	41.283%
Mesoblast Limited	1.00 USD	-126299900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	98.587%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	1434.926%
Marizyme, Inc.	24.85 Thousand USD	-4981.473%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-7793.75%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-126299900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-61.097%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	26.184%
Neon Bloom, Inc.	7938.00 USD	-15810.809%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	97.775%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-5494.932%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	7.439%
IMV Inc.	2.00 USD	-63149900.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-10425.0%
Curative Biotechnology, Inc.	-115.62 Thousand USD	1192.324%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-1296.923%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	99.979%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	46.731%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-502.608%
argenx SE	310.55 Million USD	99.593%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-10863.542%
Zenith Capital Corp.	3.00 USD	-42099900.0%
Genscript Biotech Corporation	53.33 Million USD	97.632%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-2426.0%
WPD Pharmaceuticals Inc.	0.25 USD	-505199900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	93.86%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	90.162%
Cotinga Pharmaceuticals Inc.	0.98 USD	-128877451.02%
BioStem Technologies, Inc.	658.67 Thousand USD	-91.748%
ONE Bio Corp.	4.5 Million USD	71.966%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-126299900.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	6210.009%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	14500674.053%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	91.58%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-126299900.0%
IntelGenx Technologies Corp.	71 Thousand USD	-1678.873%
Gelesis Holdings, Inc.	6.86 Million USD	81.602%
CSL Limited	5.96 Billion USD	99.979%
Cellectis S.A.	1.00 USD	-126299900.0%

Global Stocks Search

International Stem Cell Corporation (ISCO)

Inventory Summary of International Stem Cell Corporation

Annual Inventory Chart of International Stem Cell Corporation (2023 - 2005)

Historical Annual Inventory of International Stem Cell Corporation (2023 - 2005)

Peer Inventory Comparison of International Stem Cell Corporation